AB-001 (Akso Biopharmaceutical)

N/A

Report date: 2022/02/14 17:06:54

Base Information

Drug NameAB-001 (Akso Biopharmaceutical)
Drug Alias NameAB-001
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 inhibitorsB-cell-activating factor/B lymphocyte stimulator inhibitors
TargetsTumor necrosis factor ligand superfamily member 13B-cell-activating factor/B lymphocyte stimulator
Therapy Area/IndicationsGlomerulonephritis, IGALymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkso Biopharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkso Biopharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGALymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A